Behring Vaccine

Chiron Behring Vaccines is a leading biotechnology company specializing in the production of high-quality rabies vaccines for human use. Renowned for its Purified Chick Embryo Cell (PCEC) technology, the company manufactures the globally recognized rabies vaccine marketed as Rabipur (or RabAvert). Originally established as a joint venture between Chiron Corporation and the German firm Behringwerke, the company has transitioned through the portfolios of Novartis and GSK before its acquisition by Bharat Biotech in 2019. Operating from a WHO-prequalified facility in Ankleshwar, India, it remains one of the world's largest manufacturers of rabies vaccines, playing a critical role in global post-exposure prophylaxis and public health.